☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Dermatitis
Sanofi and Regeneron's Dupixent (dupilumab) Receive CHMP's Positive Opinion for Moderate-To-Severe Atopic Dermatitis in Adolescent...
June 28, 2019
Almirall Exercises its Option to License Dermira's Lebrikizumab for Atopic Dermatitis in Europe
June 26, 2019
Load more...
Back to Home